Health ❯ Healthcare ❯ Pharmaceuticals

Weight Loss

GLP-1 Drugs Mounjaro Wegovy GLP-1 Medications Obesity Treatments Semaglutide Clinical Trials GLP-1 Receptor Agonists Orforglipron Tirzepatide Ozempic Obesity Treatment Eli Lilly Injections Medication Weight Loss Injections Weight Loss Drugs GLP-1 Agonists CagriSema Medications Zepbound Amycretin Ecnoglutida Weight Loss Pills Ozempic and Wegovy Obesity Drugs Muscle Health Orforpligron Celebrity Endorsements Mounjaro (Tirzepatide) Drug Development Obesity Accessibility Medical Incidents Hormonal Treatments Medication Efficacy Compounded Medications Anti-Obesity Medications Anti-Obesity Drugs Drug Comparison Cagrisema Online Purchases GLP-1 Injections Drug Pricing Drug Trials Prescription Drugs Illegal Drugs Compounded Drugs Microdosing Prescription Medications Amylin Analogs Drug Approval GLP Agonist Drugs Injectable Drugs Orforgilpron

Innovent Says Mazdutide Tops Semaglutide in China Phase 3 Diabetes Trial

The company’s head-to-head results are self-reported and await independent review.

Lilly’s Oral GLP-1 Orforglipron Beats Farxiga and Placebo in Two Phase 3 Diabetes Trials